China Infectious Diagnostics Market Outlook to 2021

Published: August 2015
No. of Pages: 48
   

GlobalData''s new report, "China Infectious Diagnostics Market Outlook to 2021", provides key market data on the China Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Infectious Diagnostics market.
  • Global corporate-level profiles of key companies operating within the China Infectious Diagnostics market.
  • Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what''s the most preferred mode of product distribution - Identify, understand and capitalize.

China Infectious Diagnostics Market Outlook to 2021

Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Introduction 5
2.1 What Is This Report About? 5
2.2 Infectious Diagnostics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6

3 Infectious Diagnostics Market, China 8
3.1 Infectious Diagnostics Market, China, Revenue ($m), 2007-2014 8
3.2 Infectious Diagnostics Market, China, Revenue ($m), 2014-2021 10
3.2.1 Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2007-2014 12
3.2.2 Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2014-2021 14
3.3 Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2013-2014 16
3.4 Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2014 17

4 Overview of Key Companies in China, Infectious Diagnostics Market 19
4.1 F. Hoffmann-La Roche Ltd. 19
4.1.1 Company Overview 19
4.2 Abbott Laboratories 19
4.2.1 Company Overview 19
4.3 Bio-Rad Laboratories, Inc. 19
4.3.1 Company Overview 19
4.4 Siemens Healthcare 19
4.4.1 Company Overview 19
4.5 Danaher Corporation 20
4.5.1 Company Overview 20
4.6 Alere Inc. 20
4.6.1 Company Overview 20
4.7 Hologic, Inc. 20
4.7.1 Company Overview 20
4.8 Becton, Dickinson and Company 21
4.8.1 Company Overview 21
4.9 Cepheid 21
4.9.1 Company Overview 21
4.10 Qiagen N.V. 21
4.10.1 Company Overview 21
4.11 DiaSorin S.p.A 22
4.11.1 Company Overview 22

5 Infectious Diagnostics Market Pipeline Products 23

6 Financial Deals Landscape 34
6.1 Partnerships 34
6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 34
6.1.2 Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical 35

7 Recent Developments 36
7.1 Corporate Communications 36
7.1.1 Dec 04, 2014: Neogen names COO 36
7.2 Financial Announcements 36
7.2.1 Jul 21, 2015: Neogen reports record revenues and earnings 36
7.2.2 May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium 38
7.2.3 Mar 26, 2015: Neogen reports 13% increase in net income 38
7.2.4 Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18 40
7.2.5 Dec 18, 2014: Neogen reports 26% increase in net income 41
7.2.6 Sep 22, 2014: Neogen Reports 13% Net Income Increase 43
7.3 Other Significant Developments 44
7.3.1 Jun 11, 2015: Lansen subsidiary signs a distribution agreement with Bio-Rad China and expands into the clinical diagnostic market in the PRC 44

8 Appendix 45
8.1 Research Methodology 46
8.1.1 Coverage 46
8.1.2 Secondary Research 46
8.1.3 Primary Research 47
8.1.4 Company Share Analysis 47
8.1.5 Distribution Share Analysis 47
8.2 GlobalData Consulting 47
8.3 Contact Us 48
8.4 Disclaimer 48

List of Tables

Table 1: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 9
Table 2: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Table 3: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 4: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Table 5: Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 16
Table 6: Infectious Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014 18
Table 7: Infectious Diagnostics Market Pipeline Products 23
Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome 34
Table 9: Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical 35

List of Figures

Figure 1: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 8
Figure 2: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Figure 3: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 4: Infectious Diagnostics Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Figure 5: Infectious Diagnostics Market, China, Company Share (%) 2014 17

Published By: GlobalData
Product Code: GlobalData32828


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we´┐Żll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Medical Devices market as per your needs. Get the best of Medical Devices research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: